1. Home
  2. VVX vs SLNO Comparison

VVX vs SLNO Comparison

Compare VVX & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo V2X Inc.

VVX

V2X Inc.

HOLD

Current Price

$53.71

Market Cap

1.7B

ML Signal

HOLD

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

HOLD

Current Price

$48.31

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VVX
SLNO
Founded
2014
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.5B
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
VVX
SLNO
Price
$53.71
$48.31
Analyst Decision
Buy
Strong Buy
Analyst Count
10
10
Target Price
$62.60
$110.90
AVG Volume (30 Days)
369.5K
1.6M
Earning Date
11-03-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
791.53
N/A
EPS
2.51
N/A
Revenue
$4,419,142,000.00
$98,675,000.00
Revenue This Year
$4.42
N/A
Revenue Next Year
$5.45
$155.86
P/E Ratio
$21.32
N/A
Revenue Growth
5.10
N/A
52 Week Low
$41.08
$41.50
52 Week High
$63.74
$90.32

Technical Indicators

Market Signals
Indicator
VVX
SLNO
Relative Strength Index (RSI) 43.12 42.58
Support Level $54.15 $48.60
Resistance Level $55.94 $50.95
Average True Range (ATR) 1.89 2.63
MACD -0.10 0.21
Stochastic Oscillator 21.62 9.24

Price Performance

Historical Comparison
VVX
SLNO

About VVX V2X Inc.

V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: